The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Amphotericin primarily kills yeast by simply binding ergosterol
Open accessAbstract
Amphotericin B (AmB) is a prototypical small molecule natural product that can form ion channels in living eukaryotic cells and has remained refractory to microbial resistance despite extensive clinical utilization in the treatment of life-threatening fungal infections for more than half a century. It is now widely accepted that AmB kills yeast primarily via channel-mediated membrane permeabilization. Enabled by the iterative cross-coupling-based synthesis of a functional group deficient derivative of this natural product, we have discovered that channel formation is not required for potent fungicidal activity. Alternatively, AmB primarily kills yeast by simply binding ergosterol, a lipid that is vital for many aspects of yeast cell physiology. Membrane permeabilization via channel formation represents a second complementary mechanism that further increases drug potency and the rate of yeast killing. Collectively, these findings ( i ) reveal that the binding of a physiologically important microbial lipid is a powerful and clinically validated antimicrobial strategy that may be inherently refractory to resistance, ( ii ) illuminate a more straightforward path to an improved therapeutic index for this clinically vital but also highly toxic antifungal agent, and ( iii ) suggest that the capacity for AmB to form protein-like ion channels might be separable from its cytocidal effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AmB binds to ergosterol, forming microporous channels on the cell membrane and enabling the drug’s fungicidal activity.”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Downregulation of ergosterol may therefore reduce the exposure of AmB drug targets [64].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [64]
In the citing paper
“These amphipathic compounds act as a sponge extracting ergosterol from the fungal cell membrane, leading to the formation of pores, causing leakage of cellular components and ultimately death of the fungal cell [32,33].”
From Antifungal therapy of Candida biofilms: Past, present and future (2023) · cites this paper as [33]
In the citing paper
“Amphotericin B (AMB), a polyene class of antifungal drug, irreversibly binds to ergosterol, resulting in fungal cell death.”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [615]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry
Ejsing, C. S., Sampaio, J. L., Surendranath, V., Duchoslav, E., Ekroos, K., Klemm, R. W., Simons, K., & Shevchenko, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811700106 · Cited by 1,053
Antibacterial agents based on the cyclic d,l-α-peptide architecture
Fernandez‐Lopez, S., Kim, H.-S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A. B., Kraehenbuehl, K., Long, G. V., Weinberger, D. A., Wilcoxen, K., et al. (2001) · Nature · doi:10.1038/35086601 · Cited by 938
Taubes, G. (2008) · Science · doi:10.1126/science.321.5887.356 · Cited by 757
How do the polyene macrolide antibiotics affect the cellular membrane properties?
Bolard, J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(86)90002-x · Cited by 757
KRUIJFF, B. D., & DEMEL, R. A. (1974) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(74)90332-0 · Cited by 609
Knapp, D. M., Gillis, E. P., & Burke, M. D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901416p · Cited by 559
Self-citationAn Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, L., Hillman, J. D., Zachariah, C., Kuipers, O. P., KRUIJFF, B. D., & Breukink, E. J. (2006) · Science · doi:10.1126/science.1129818 · Cited by 502
Gillis, E. P., & Burke, M. D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0716204 · Cited by 488
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 612
Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
Mwenechanya, R., Kovářová, J., Dickens, N. J., Mudaliar, M., Herzyk, P., Vincent, I. M., Weidt, S. K., Burgess, K. E., Burchmore, R., Pountain, A. W., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005649 · Cited by 64
Shahina, Z., Ndlovu, E., Persaud, O., Sultana, T., & Dahms, T. E. S. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03183-22 · Cited by 67
Ergosterol distribution controls surface structure formation and fungal pathogenicity
Choy, H. L., Gaylord, E. A., & Doering, T. L. (2023) · mBio · doi:10.1128/mbio.01353-23 · Cited by 63
An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety
Antillón, A., de Vries, A. H., Espinosa-Caballero, M., Falcón-González, J. M., Romero, D. F., González–Damián, J., Jiménez-Montejo, F. E., León‐Buitimea, A., López‐Ortíz, M., Magaña, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162171 · Cited by 62
Systemic Antifungal Agents: Current Status and Projected Future Developments
Seyedmousavi, S., Rafati, H., İlkit, M., Tolooe, A., Hedayati, M. T., & Verweij, P. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_5 · Cited by 62
Synthesis and evaluation of anti-fungal activities of sodium alginate-amphotericin B conjugates
Ravichandran, V., & Jayakrishnan, A. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.030 · Cited by 61
In vitro polymyxin activity against clinical multidrug-resistant fungi
Yousfi, H., Ranque, S., Rolain, J., & Bittar, F. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0521-7 · Cited by 61
Castro, I. G., Shortill, S. P., Dziurdzik, S. K., Cadou, A., Ganesan, S., Valenti, R., David, Y., Davey, M., Mattes, C., Thomas, F. B., et al. (2022) · eLife · doi:10.7554/elife.74602 · Cited by 60
Psd1 Effects on Candida albicans Planktonic Cells and Biofilms
Gonçalves, S., Silva, P. M., Felício, M. R., de Medeiros, L. N., Kurtenbach, E., & Santos, N. C. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00249 · Cited by 63
Current perspectives on natamycin in ocular fungal infections
Patil, A., Lakhani, P. M., & Majumdar, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.07.015 · Cited by 59
Fernandes, C. M., & Poeta, M. D. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792288 · Cited by 61
Shivarathri, R., Jenull, S., Stoiber, A., Chauhan, M., Mazumdar, R., Singh, A., Nogueira, F., Kuchler, K., Chowdhary, A., & Chauhan, N. (2020) · mSphere · doi:10.1128/msphere.00973-20 · Cited by 59
Chen, Y., Yan, Q., Ji, Y., Bai, X., Li, D., Mu, R., Guo, K., Yang, M., Tao, Y., Gershenzon, J., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.033 · Cited by 59
Vesicle Leakage Reflects the Target Selectivity of Antimicrobial Lipopeptides from Bacillus subtilis
Fiedler, S., & Heerklotz, H. H. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.09.021 · Cited by 59
Site-Selective Reactions with Peptide-Based Catalysts
Giuliano, M. W., & Miller, S. J. (2015) · Topics in current chemistry · doi:10.1007/128_2015_653 · Cited by 59
Caffrey, P., Poire, E. D., Sheehan, J., & Sweeney, P. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7474-z · Cited by 59
Dong, P., Zong, C., Dagher, Z., Hui, J., Li, J., Zhan, Y., Zhang, M., Mansour, M. K., & Cheng, J. (2021) · Science Advances · doi:10.1126/sciadv.abd5230 · Cited by 56
Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics
Mascarenhas, M., Chaudhari, P., & Lewis, S. A. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02541-x · Cited by 60
Wong, S. S. W., Samaranayake, L. P., & Seneviratne, C. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.009 · Cited by 57
Haro-Reyes, T., Díaz-Peralta, L., Galván‐Hernández, A., Rodríguez‐López, A., Rodríguez‐Fragoso, L., & Ortega‐Blake, I. (2022) · Membranes · doi:10.3390/membranes12070681 · Cited by 59
Waśko, P., Luchowski, R., Tutaj, K., Grudziński, W., Adamkiewicz, P., & Gruszecki, W. I. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300143n · Cited by 56
Demirci, T., Erginer, M., Eroğlu, M. S., Hemberger, J., & Öner, E. T. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105255 · Cited by 56
Stubbendieck, R. M., & Straight, P. D. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005722 · Cited by 49
Lewandowska, A., Soutar, C. P., Greenwood, A. I., Nimerovsky, E., Lio, A. M. D., Holler, J. T., Hisao, G. S., Khandelwal, A., Zhang, J., SantaMaria, A. M., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00685-4 · Cited by 55
Self-citationAlpizar-Sosa, E. A., Ithnin, N. R., Wei, W., Pountain, A. W., Weidt, S. K., Donachie, A. M., Ritchie, R., Dickie, E. A., Burchmore, R., Denny, P. W., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010779 · Cited by 59
Electronic tuning of site-selectivity
Wilcock, B. C., Uno, B. E., Bromann, G. L., Clark, M. J., Anderson, T. M., & Burke, M. D. (2012) · Nature Chemistry · doi:10.1038/nchem.1495 · Cited by 55
Self-citationSocías, S. B., González‐Lizárraga, F., Ávila, C. L., Vera, C., Acuña, L., Sepulveda-Diaz, J. E., Bel, E. A. D., Raisman‐Vozari, R., & Chehín, R. N. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.002 · Cited by 55
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 61
Sterol Sponge Mechanism Is Conserved for Glycosylated Polyene Macrolides
Guo, X., Zhang, J., Li, X., Xiao, E., Lange, J. D. T., Rienstra, C. M., Burke, M. D., & Mitchell, D. A. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00148 · Cited by 57
Self-citationAntifungal therapy of Candida biofilms: Past, present and future
Ajetunmobi, O. H., Badali, H., Romo, J. A., Ramage, G., & Lopez-Ribot, J. L. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100126 · Cited by 52
Novel antifungal agents: a patent review (2013 - present)
Castelli, M. V., Derita, M., & López, S. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1261113 · Cited by 53
Wu, X., Hu, Q., Liang, X., & Fang, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.133288 · Cited by 52
Schiavone, M., Formosa‐Dague, C., Elsztein, C., Teste, M.-A., Martin‐Yken, H., de Morais, M. A., Dague, É., & François, J. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01213-16 · Cited by 52
Guirao-Abad, J. P., Sánchez-Fresneda, R., Alburquerque-González, B., Hernández, J. A., & Argüelles, J. C. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.03.005 · Cited by 55
Transcriptional Responses of Candida albicans to Antimicrobial Peptide MAF-1A
Wang, T., Xiu, J., Zhang, Y., Wu, J., Ma, X., Wang, Y., Guo, G., & Shang, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00894 · Cited by 51
Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 54
Antifungal resistance in Aspergillus terreus: A current scenario
Vahedi‐Shahandashti, R., & Lass‐Flörl, C. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103247 · Cited by 51
Chudzik, B., Bonio, K., Dąbrowski, W., Pietrzak, D., Niewiadomy, A., Olender, A., Małodobry, K., & Gagoś, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49425-1 · Cited by 49
Rane, H. S., Bernardo, S. M., Raines, S. M., Binder, J., Parra, K. J., & Lee, S. A. (2013) · Eukaryotic Cell · doi:10.1128/ec.00118-13 · Cited by 49
Echinocandins in Ocular Therapeutics
Patil, A., & Majumdar, S. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0186 · Cited by 49
Sandhya, M., Aparna, V., Suresh, M. K., Raja, B., Jayakumar, R., & Sankaran, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.028 · Cited by 49
Fungal strains and the development of tolerance against natamycin
Streekstra, H., Verkennis, A. E. E., Jacobs, R., Dekker, A., Stark, J., & Dijksterhuis, J. (2016) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2016.08.006 · Cited by 47
Rossi, S. A., de Oliveira, H. C., Agreda-Mellon, D., Lucio, J., Mendes-Giannini, M. J. S., García-Cambero, J. P., & Zaragoza, O. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01921-19 · Cited by 48
Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine
Yñigez‐Gutierrez, A. E., & Bachmann, B. O. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00246 · Cited by 51
Unmasking the Amphotericin B Resistance Mechanisms in Candida haemulonii Species Complex
Silva, L. N., Oliveira, S. S. C., Magalhães, L. B., Andrade-Neto, V. V., Torres-Santos, E. C., de Carvalho, M. D. C., Pereira, M. D., Branquinha, M. H., & dos Santos, A. L. S. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00117 · Cited by 50
Revie, N. M., Iyer, K. R., Maxson, M. E., Zhang, J., Yan, S., Fernandes, C. M., Meyer, K. J., Chen, X., Skulska, I., Fogal, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31308-1 · Cited by 48
Self-citationAlvarez‐Lorenzo, C., García‐González, C. A., Bucio, E., & Concheiro, Á. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1178719 · Cited by 49
Past, Present, and Future of Antifungal Drug Development
Shukla, P. K., Singh, P., Yadav, R. K., Pandey, S., & Bhunia, S. S. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_4 · Cited by 48
Molecular targets for antifungals in amino acid and protein biosynthetic pathways
Kuplińska, A., & Rząd, K. (2021) · Amino Acids · doi:10.1007/s00726-021-03007-6 · Cited by 46
Digital microfluidics for time-resolved cytotoxicity studies on single non-adherent yeast cells
Kumar, P. T., Vriens, K., Cornaglia, M., Gijs, M. A. M., Kokalj, T., Thevissen, K., Geeraerd, A. H., Cammue, B. P. A., Puers, R., & Lammertyn, J. (2015) · Lab on a Chip · doi:10.1039/c4lc01469c · Cited by 45
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects
Lu, X., Zhou, J., Ming, Y., Wang, Y., He, R., Li, Y., Feng, L., Zeng, B., Du, Y., & Wang, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.013 · Cited by 50
Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance
Jukic, E., Blatzer, M., Posch, W., Steger, M., Binder, U., Lass‐Flörl, C., & Wilflingseder, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00670-17 · Cited by 46
Zakaria, A., Osman, M., Dabboussi, F., Rafei, R., Mallat, H., Papon, N., Bouchara, J., & Hamzé, M. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.08.007 · Cited by 46
Jafari, M., Abolmaali, S. S., Tamaddon, A. M., Zomorodian, K., & Sarkari, B. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0482 · Cited by 44
Yao, T., Liu, Z., Li, T., Zhang, H., Liu, J., Li, H., Che, Q., Zhu, T., Li, D., & Li, W. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-0943-6 · Cited by 42
Blosser, S. J., Merriman, B., Grahl, N., Chung, D., & Cramer, R. A. (2014) · Microbiology · doi:10.1099/mic.0.080440-0 · Cited by 45
O’Meara, T. R., Veri, A. O., Polvi, E. J., Li, X., Valaei, S. F., Diezmann, S., & Cowen, L. E. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006142 · Cited by 45
Xu, X., Peng, X., Chen, H., Chen, J., Meng, Y., & Fang, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134659 · Cited by 41
Chudzik, B., Koselski, M., Czuryło, A., Trębacz, K., & Gagoś, M. (2015) · European Biophysics Journal · doi:10.1007/s00249-014-1003-8 · Cited by 41
Rational Design of an Antifungal Polyacrylamide Library with Reduced Host-Cell Toxicity
Schaefer, S., Phuong, P. T. T., Brunke, S., Hube, B., Jung, K., Lenardon, M. D., & Boyer, C. A. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c05020 · Cited by 41
The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs
Noël, T. (2012) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2012.04.004 · Cited by 40
Stubbendieck, R. M., & Straight, P. D. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005807 · Cited by 8
The assimilation of different carbon sources in Candida albicans: Fitness and pathogenicity
Lok, B., Adam, M. A. A., Kamal, L. Z. M., Chukwudi, N. A., Sandai, R., & Sandai, D. (2021) · Medical Mycology · doi:10.1093/mmy/myaa080 · Cited by 39
Lee, H.-S., & Kim, Y. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2110.10014 · Cited by 40
Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance
Mehta, D., Saini, V., & Bajaj, A. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00151b · Cited by 44
Investigation of the antifungal activity of carvacrol against strains ofCryptococcus neoformans
Nóbrega, R. D. O., Teixeira, A. P. D. C., de Oliveira, W. A., Lima, E. D. O., & Lima, I. O. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2016.1172319 · Cited by 39
Sterol-Response Pathways Mediate Alkaline Survival in Diverse Fungi
Brown, H. E., Telzrow, C. L., Saelens, J. W., Fernandes, L., & Alspaugh, J. A. (2020) · mBio · doi:10.1128/mbio.00719-20 · Cited by 36
Natamycin, a Biofungicide for Managing Major Postharvest Fruit Decays of Citrus
Chen, D., Forster, H., & Adaskaveg, J. E. (2020) · Plant Disease · doi:10.1094/pdis-08-20-1650-re · Cited by 39
Bari, V. K., Sharma, S., Alfatah, M., Mondal, A. K., & Ganesan, K. (2015) · Scientific Reports · doi:10.1038/srep09685 · Cited by 40
Zielińska, J., Wieczór, M., Bączek, T., Gruszecki, M., & Czub, J. (2016) · Scientific Reports · doi:10.1038/srep19109 · Cited by 38
Nishimura, S., & Matsumori, N. (2020) · Natural Product Reports · doi:10.1039/c9np00059c · Cited by 37
Identification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi
Prole, D. L., & Taylor, C. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042404 · Cited by 37
Hussain, S., Tai, B., Ali, M., Jahan, I., Sakina, S., Wang, G., Zhang, X., Yin, Y., & Xing, F. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04008-23 · Cited by 38
Neumann, A., Bagiński, M., Winczewski, S., & Czub, J. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.02.029 · Cited by 37
Yamamoto, T., Umegawa, Y., Yamagami, M., Suzuki, T., Tsuchikawa, H., Hanashima, S., Matsumori, N., & Murata, M. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00180 · Cited by 37
Medical and Nonmedical Applications of Synthetic Transmembrane Anion Transporters
Rathnaweera, U. M. C., Chowdhury, S. M., Salam, R., & Busschaert, N. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00129 · Cited by 38
Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B
Alvarez, C., Shin, D. H., & Kwon, G. S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1948-7 · Cited by 36
Humisto, A., Jokela, J., Teigen, K., Wahlsten, M., Permi, P., Sivonen, K., & Herfindal, L. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.03.010 · Cited by 36
Collett, C. F., Kitson, C., Baker, N., Steele-Stallard, H. B., Santrot, M.-V., Hutchinson, S., Horn, D., & Alsford, S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00795-19 · Cited by 36
Blocking and dislocation of Candida albicans Cdr1p transporter by styrylquinolines
Szczepaniak, J., Cieślik, W., Romanowicz, A., Musioł, R., & Krasowska, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.044 · Cited by 35
Combining experimental strategies for successful target deconvolution
Wilkinson, I. V. L., Terstappen, G. C., & Russell, A. J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.016 · Cited by 36
Persistence and drug tolerance in pathogenic yeast
Bojsen, R. K., Regenberg, B., & Folkesson, A. (2016) · Current Genetics · doi:10.1007/s00294-016-0613-3 · Cited by 33
A synthetic peptide mimic kills Candida albicans and synergistically prevents infection
Schaefer, S., Vij, R., Sprague, J. L., Austermeier, S., Dinh, H., Judzewitsch, P. R., Müller‐Loennies, S., Silva, T. L., Seemann, E. A., Qualmann, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50491-x · Cited by 41
Histone deacetylase–mediated regulation of endolysosomal pH
Prasad, H., & Rao, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002025 · Cited by 35
Perczyk, P., Wójcik, A., Wydro, P., & Broniatowski, M. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183136 · Cited by 36
Woerly, E. M., Miller, J. E., & Burke, M. D. (2013) · Tetrahedron · doi:10.1016/j.tet.2013.05.050 · Cited by 34
Self-citationRNAseq analysis of Aspergillus fumigatus in blood reveals a just wait and see resting stage behavior
Irmer, H., Tarazona, S., Sasse, C., Olbermann, P., Loeffler, J., Krappmann, S., Conesa, A., & Braus, G. H. (2015) · BMC Genomics · doi:10.1186/s12864-015-1853-1 · Cited by 37
de Ghellinck, A., Fragneto, G., Laux, V., Haertlein, M., Jouhet, J., Sferrazza, M., & Wacklin, H. P. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.06.006 · Cited by 33
Janout, V., Schell, W. A., Thévenin, D., Yu, Y., Perfect, J. R., & Regen, S. L. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00463 · Cited by 33
Kim, H.-J., Han, C.-Y., Park, J., Oh, S., Kang, S.-H., Choi, S.-S., Kim, J., Kwak, J., & Kim, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-31801-y · Cited by 33
Amphotericin B as antiviral drug: Possible efficacy against COVID-19
Al-Khikani, F. H. O. (2020) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_147_20 · Cited by 33
Discovery of Amphamide, a Drug Candidate for the Second Generation of Polyene Antibiotics
Tevyashova, A. N., Бычкова, Е. Н., Solovieva, S. E., Zatonsky, G. V., Grammatikova, N. E., Борисовна, И. Е., Павловна, М. Е., Трещалин, И. Д., Переверзева, Э. Р., Bykov, E. E., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00068 · Cited by 33
Hussain, M. K., Ahmed, S., Khan, A., Siddiqui, A. J., Khatoon, S., & Jahan, S. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115010 · Cited by 34
Liang, X., Chen, D., Wang, J., Liao, B., Shen, J., Ye, X., Wang, Z., Zhu, C., Gou, L., Zhou, X., et al. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00245-0 · Cited by 32
New antifungal strategies and drug development against WHO critical priority fungal pathogens
Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., & Tan, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662442 · Cited by 38
Assessment of silibinin as a potential antifungal agent and investigation of its mechanism of action
Yun, D. G., & Lee, D. G. (2017) · IUBMB Life · doi:10.1002/iub.1647 · Cited by 33
Small-molecule inhibitors for the Prp8 intein as antifungal agents
Li, Z., Tharappel, A. M., Xu, J., Lang, Y., Green, C. M., Zhang, J., Lin, Q., Chaturvedi, S., Zhou, J., Belfort, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008815118 · Cited by 31
Sukumaran, A., Ball, B., Krieger, J. R., & Geddes‐McAlister, J. (2022) · mBio · doi:10.1128/mbio.01687-22 · Cited by 34
Stubbendieck, R. M., & Straight, P. D. (2017) · Journal of Bacteriology · doi:10.1128/jb.00186-17 · Cited by 33
Thanki, K., Date, T., & Jain, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00662 · Cited by 33
Metadata
- Authors
- Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., & Burke, M. D.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-01-17
- Volume
- 109
- Issue
- 7
- Pages
- 2234-2239
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3289339
- OpenAlex
- W1987640473
- Cited by
- 608
- References
- 50
- Citations by year
- 2026: 42 · 2025: 42 · 2024: 34 · 2023: 49 · 2022: 45 · 2021: 56 · 2020: 53 · 2019: 50 · 2018: 32 · 2017: 44 · 2016: 44 · 2015: 40 · 2014: 36 · 2013: 30 · 2012: 11
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Bristol-Myers Squibb
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM080436, GM080436)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- amphotericin B, ergosterol binding, yeast cell death, antifungal mechanism, ion channel formation, membrane permeabilization, fungal drug resistance, natural product derivatives, therapeutic index, antifungal toxicity
- MeSH terms
- Amphotericin B, Antifungal Agents, Ergosterol, Saccharomyces cerevisiae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review